IISc team reports antibiotic combination that may reverse drug-resistant TB
Indian Institute of Science researchers say a combination of existing antibiotics can reverse drug resistance in tuberculosis, according to reports from The Times of India and The Hindu.

Researchers at the Indian Institute of Science (IISc) have reported finding a combination of antibiotics that can reverse drug resistance in tuberculosis, according to reports by The Times of India and The Hindu on November 16, 2026.
Both outlets described the work as involving a mix of antibiotics that restored susceptibility of resistant Mycobacterium tuberculosis strains to treatment, though they did not provide identical technical details. The reports attribute the finding to IISc researchers and say the combination overcame resistance in the studied strains.
What was reported
The Times of India and The Hindu each reported the IISc finding on the same day and presented it as a laboratory result from the institute’s researchers. Both accounts state that the antibiotic combination reversed drug resistance in TB strains examined by the team.
Neither report provided extensive methodological detail, patient data, or information on clinical testing in humans. According to the outlets, the work was carried out by researchers at IISc; beyond that, the articles do not specify trial stage, sample size, or timelines for clinical use.
Why it matters
If confirmed and translated into clinical practice, an approach that reverses drug resistance could affect treatment options for drug-resistant tuberculosis. The Times of India and The Hindu report the IISc finding but do not claim independent confirmation beyond the institute’s research as presented in their articles.
Sources
This story was written from reports by these outlets. Read the originals:

